Working… Menu
Trial record 36 of 546 for:    "Viral Infectious Disease" | "Peginterferon alfa-2a"

Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01686789
Recruitment Status : Completed
First Posted : September 18, 2012
Last Update Posted : February 24, 2016
Information provided by (Responsible Party):
Faisal M Sanai, King Abdulaziz Medical City

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2015
Actual Study Completion Date : August 2015